IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
25.85
-0.32 (-1.22%)
Nov 20, 2026, 12:10 PM EST - Market open
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.5 billion as of November 20, 2026. It is the 5,428th most valuable company in the world and the 1,579th biggest in the United States. Its market cap has decreased by 13.94% in one year.
Market Cap
2.50B
Enterprise Value
1.38B
1-Year Change
-13.94%
Global Rank
Country Rank
#1,579 United States
Category
ChartMarket Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.50B, an increase of 1,059.53%. That is a compound annual growth rate of 38.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.50B | -17.52% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 2.94B |
| ADMA Biologics | 2.92B |
| Celcuity | 2.81B |
| MBX Biosciences | 2.64B |
| Xencor | 2.58B |
| Zai Lab | 2.47B |
| NewAmsterdam Pharma Company | 2.35B |
| Arcus Biosciences | 2.28B |